ÌÇÐÄÆƽâ°æ

EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2025 (in billion Indian rupees)

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

June 2025

Region

India

Survey time period

FY 2015 to FY 2025

Supplementary notes

India's financial year begins in April and ends in March. For example, FY 2025 started in April 2024 and ended in March 2025. 

One Indian rupee is equal to 0.01 euros and 0.011 U.S. dollars (as of August 2025).  

Citation formats

GSK Pharmaceuticals' EBITDA in India FY 2015-2025

Published by A. Minhas, Oct 13, 2025

In fiscal year 2025, GlaxoSmithKline Pharmaceuticals Limited in India reported around Indian rupees as earnings before interest, tax, depreciation and amortization. This was an increase compared to the previous fiscal year's ** rupees worth EBITDA. In financial year 2025, GSK ranked as the leading brand in the private vaccine market and dermatology segment.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " GlaxoSmithKline Pharmaceuticals Limited India "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you GlaxoSmithKline Pharmaceuticals Limited India

Market overview

6

GSK India - key figures

6

Main competitiors

4

Product portfolio

3

Further Content: You might find this interesting as well

Topics

GlaxoSmithKline Pharmaceuticals Limited IndiaGlobal pharmaceutical industrySanofiPfizerJohnson & Johnson
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.